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Abstract
Multiple myeloma (MM) is a hematological malignancy characterized by frequent chromo-
some abnormalities. However, the molecular basis for this genome instability remains un-
known. Since both impaired and hyperactive double strand break (DSB) repair pathways
can result in DNA rearrangements, we investigated the functionality of DSB repair in MM
cells. Repair kinetics of ionizing-radiation (IR)-induced DSBs was similar in MM and normal
control lymphoblastoid cell lines, as revealed by the comet assay. However, four out of
seven MM cell lines analyzed exhibited a subset of persistent DSBs, marked by γ-H2AX
and Rad51 foci that elicited a prolonged G2/M DNA damage checkpoint activation and
hypersensitivity to IR, especially in the presence of checkpoint inhibitors. An analysis of the
proteins involved in DSB repair in MM cells revealed upregulation of DNA-PKcs, Artemis
and XRCC4, that participate in non-homologous end joining (NHEJ), and Rad51, involved
in homologous recombination (HR). Accordingly, activity of both NHEJ and HR were elevat-
ed in MM cells compared to controls, as determined by in vivo functional assays. Interest-
ingly, levels of proteins involved in a highly mutagenic, translocation-promoting, alternative
NHEJ subpathway (Alt-NHEJ) were also increased in all MM cell lines, with the Alt-NHEJ
protein DNA ligase IIIα, also overexpressed in several plasma cell samples isolated from
MM patients. Overactivation of the Alt-NHEJ pathway was revealed in MM cells by larger
deletions and higher sequence microhomology at repair junctions, which were reduced by
chemical inhibition of the pathway. Taken together, our results uncover a deregulated DSB
repair in MM that might underlie the characteristic genome instability of the disease, and
could be therapeutically exploited.
Introduction
Multiple myeloma (MM) is a clonal disorder of B-cells at the last stage of differentiation. Ge-
nome instability is a prominent feature of MM cells, and includes ploidy changes, deletions,
amplifications and chromosomal translocations mainly involving the IGH locus on
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chromosome 14q32 [1]. However, the underlying molecular mechanisms for the generation of
this instability are unclear. Numerical chromosome abnormalities may be generated by centro-
some amplification or alterations in the spindle assembly checkpoint (SAC) [2,3]. On the other
hand, structural abnormalities, such as chromosomal deletions or translocations, might arise
from alterations in the repairing of DNA double strand breaks (DSBs).
DSBs can be generated exogenously, by the exposure to a variety of genotoxic agents, or en-
dogenously, during normal cellular processes such as DNA replication, or lymphoid V(D)J and
class-switch recombination (CSR), occurring at the IGH locus on chromosome 14q32 [4]. One
of the first responses to the presence of a DSB is the phosphorylation of histone H2AX by mem-
bers of the PI3-K family, such as ataxia telangiectasia mutated (ATM), ataxia telangiectasia and
Rad3 related (ATR) or DNA-dependent protein kinase catalytic subunit (DNA-PKcs) [4,5].
Once damage is detected, DSBs can be repaired by two major pathways: homologous recombi-
nation (HR) and non-homologous end joining (NHEJ) [6,7,8]. During HR, the sister chromatid
is used as a template to copy the missing information into the broken locus. In contrast, NHEJ
proceeds by a direct ligation of the two broken ends, and can produce short deletions or inser-
tions [7]. The pathway is initiated at the sites of DSBs by the Ku70/Ku86 heterodimer that binds
the broken DNA ends, and recruits the DNA-PKcs. The DNA-PK complex stabilizes the DNA
ends and a ligation reaction is then carried out by the DNA ligase IV/XRCC4 complex. The role
of HR and NHEJ in cancer is complex since both underactivity and overactivity can contribute
to genome instability and to the development or progression of the disease [9,10,11,12].
Recent results have shown the existence of an alternative, and still poorly defined end join-
ing pathway (Alt-NHEJ), that is mainly operative when the classical NHEJ pathway is impaired
[13,14]. Alt-NHEJ requires more extensive end resection, and frequently uses microhomology
in the repair. Moreover, it has been implicated in the chromosomal translocations that give rise
to lymphoid cancers [14,15,16,17].
Here, we investigated the functionality of DSB repair in MM by different approaches. Our
results showed that several MM cell lines accumulate a subset of persistent DSBs after irradia-
tion that makes them hypersensitive to IR and dependent on a functional G2/M checkpoint for
survival. However, NHEJ, HR and Alt-NHEJ repair pathways are upregulated in MM cells
probably contributing to the repair of endogenous DNA damage, but increasing genome insta-
bility, which may result in disease progression and acquisition of drug resistances.
Materials and Methods
Ethics statement
The use of clinical samples for investigation was approved by the Ethical Committee of the
University Hospital of Salamanca and patients gave their written consent for that use.
Cells and culture conditions
The human myeloma cell lines, NCI-H929 and MM1S were acquired from ATCC (American
Type Culture Collection) and JJN3, RPMI-8226, U266, OPM2 and IM9, from DMSZ
(Deuthche Sammlung von Mikroorganismen and Zellkulturen). LINF167, LINF692 and
LINF903, Epstein-Barr virus (EBV)–transformed B-cell lines established from 3 healthy indi-
viduals, were obtained from the National DNA Bank of the University of Salamanca (Spain).
MM and LINF cell lines were cultured in RPMI 1640-L-Glutamine medium (Sigma-Aldrich, St
Louis, MO) supplemented with 10% of fetal bovine serum (FBS) (Sigma-Aldrich) and antibiot-
ics (Gibco Life Technologies, Grand Island, NY). HeLa and HCT116 were obtained from the
ATCC and were cultured in DMEM supplemented with L-glutamine (Sigma-Aldrich), 10%
FBS and antibiotics. All cells were incubated at 37°C in a 5% CO2 atmosphere. The presence of
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mycoplasma was routinely checked with MycoAlert kit (Lonza, Basel, Switzerland) and only
mycoplasma free cells were used in the experiments. Bone marrow (BM) samples were ob-
tained from 5 patients with MM with written informed consent in accordance with the Decla-
ration of Helsinki.
Cell irradiation
Cells were irradiated during the exponential phase of cell growth with γ-rays using a Gamma-
cell 1000 Elite irradiator (Cesium137), at a dose rate of 243 cGy/min. Samples were collected at
the indicated times after irradiation and processed for flow cytometry or inmunofluorescence
staining.
Flow cytometry analysis of γH2AX
Cells were fixed in 1ml 70% ethanol, rehydrated in phosphate buffer saline (PBS) and permea-
bilized on ice by incubation for 15 min in PBS containing 0.25% Triton X-100. Antibody stain-
ing was performed by incubation for 2h with anti-phospho-Histone H2AX (Ser-139) antibody
(mouse, Merck Millipore, Darmstadt, Germany) diluted 1:1,000 in 100 μl of 1% BSA in PBS.
Cells were washed and resuspended in secondary antibody (Alexa Fluor 488 goat anti-mouse
IgG (H+L), Invitrogen, Carlsbad, CA) diluted 1:1,000 in 1% BSA in PBS and incubated 1h at
RT. A Becton Dickinson (Mountain View, CA) FACSCalibur was used to measure γH2AX and
DNA content after washing and resuspending cells in 500 μl of PI/RNase staining solution
(Immunostep, Salamanca, Spain).
Inmunofluorescence staining
Cells (50,000) were mounted onto glass slides by cytospinning for 10 min at 1,000 rpm. Cells
were fixed in 2% paraformaldehyde for 20 min, permeabilized in 0.2% Triton X-100 in PBS for
10 min, blocked in 3% BSA in PBS for 30 min and incubated with anti–γ-H2AX (Millipore) or
anti-Rad51 (mouse, Santa Cruz Biotechnology, Santa Cruz, CA) at 1:1,000 dilution for 2h.
After washing, slides were incubated with fluorescent secondary antibodies (1:1,000, Alexa
Fluor 488 goat anti-mouse IgG or Alexa Fluor 568 anti-rabbit) for 1h. Slides were mounted
with ProLong Gold antifade reagent (Invitrogen) and images were acquired using a DeltaVi-
sion system made up of a Olympus IX71 microscope, a Photometrics Coolsnap camera and
sofWoRx software. A 60X oil immersion objective was used.
Comet assay
Cells were treated with the apoptosis inhibitor Z-VAD-FMK (CliniSciences, Barcelona, Spain)
at 30 μM, and then irradiated with 40 Gy of IR. Samples were collected at different time points
and processed for neutral comet assay as described previously [18] with some modifications.
Briefly, cell density were adjusted to 105 cells/ml in ice-cold PBS and mixed with LMAgarose
(Trevigen, Gaithersburg, MD), at 37°C, at a ratio of 1: 10 (v/v). Cell suspensions (25 μl) were
immediately transferred onto CometSlide slides (20 well slides) and placed at 4°C for 10 min-
utes. Slides were submerged in N1 lysis solution [18] and incubated overnight at 37°C in the
dark. After rinsing in N2 buffer [18], slides were subjected to electrophoresis in N2 solution for
30 min at 1V/cm. Cells were stained with ethidium bromide and analyzed with a fluorescence
microscope (Zeiss Axioplan 2) equipped with a Hamamatsu Orca-EC camera. Images were ob-
tained using Openlab software. At least 100 images per sample and experiment were analyzed.
Tail moment was determined by the OpenComet software [19].
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Cell cycle analysis
Cells were washed in PBS and fixed in 70% ethanol for later use. Cells were rehydrated with
PBS, resuspended in 500 μl of PI/RNase staining solution (Immunostep), and incubated for 20
minutes at RT in the dark. Samples were analyzed using a FACSCalibur flow cytometer.
Cell apoptosis assays
Apoptosis was measured using an annexin V-fluorescein isothiocyanate/propidium iodide (PI)
double staining (Immunostep, Spain) according to the manufacturer's procedure.
Immunoblotting
Cells were washed with PBS and lysed in ice-cold lysis buffer (140 mmol/l NaCl, 50 mmol/l
EDTA, 10% glycerol, 1% Nonidet P-40, 20 mmol/l Tris HCl pH 7) containing protease inhibi-
tors (Complete, Roche Applied Science, Indianapolis). Protein concentration was measured
using the Bradford assay (BioRad, Hercules, CA). Protein samples (20 μg/lane) were subjected
to SDS-PAGE and transferred to PVDF membrane (BioRad). After blocking, membranes were
incubated with anti-human antibodies. The following primary antibodies were used: anti-Ku70
(A-9, mouse, Santa Cruz Biotechnology), anti-Ku86 (S10B1, mouse, Santa Cruz Biotechnolo-
gy), anti DNA-PKcs (rabbit, Abcam, Cambridge, UK), anti-DNA ligase IV (rabbit, Abcam),
Anti-Artemis (goat, Abcam), anti-XRCC4 (A-7, mouse, Santa Cruz Biotechnology), anti-DNA
ligase IIIα (1F1, mouse, Gene Tex, Irvine, CA, USA), anti-WRN (H-300, rabbit, Santa Cruz
Biotechnology), anti-Rad51 (Rabbit, Santa Cruz Biotechnology). Horseradish peroxidase–
linked donkey anti-rabbit, anti-mouse or anti-goat antibodies (Santa Cruz Biotechnology)
were used as secondary antibodies at 1:5,000 dilution. Immunoblots were incubated for 1h at
RT and developed using enhanced chemiluminescence western blotting detection reagents
(Amersham Biosciences, Piscataway, NJ).
NHEJ assays
The end joining reporter plasmid pEGFP-Pem1-Ad2 was used to determine the in vivo levels
of NHEJ [20]. Digestion withHindIII or I-SceI enzymes eliminates the Ad2 sequence within
Pem1 intron and generates compatible or incompatible ends, respectively. EGFP signal can be
recovered if the transfected cells possess end joining activity to recircularize the linear plasmids.
pDSRed2-N1 plasmid (Clontech, Palo Alto, CA, USA) was cotransfected with either linearized
pEGFP-Pem1-Ad2 or supercoiled pEGFP-Pem1 (obtained by religation of HindIII-digested
pEGFP-Pem1-Ad2) to evaluate the transfection efficiency. Red-versus green curves were gen-
erated for the different cell lines with varying amounts of red and green plasmids to avoid mea-
surements near the plateau region. Higher numbers of GFP+ compared to DsRed+ cells were
obtained even when increased amounts of red vs GFP plasmid were assayed, as previously de-
scribed [21]. We fixed an amount of 2 μg of pDSRed2-N1 and 0.5 μg of either linearized
pEGFP-Pem1-Ad2 or supercoiled pEGFP-Pem1 for the experiments. One million cells were
transfected using the Amaxa Cell Line Nucleofector Kit V and Amaxa Nucleofector device
(Lonza, Allendale, NJ, USA). Programs used were X-005 for U266 cell line, T-016 for H929
and JJN3, S-020 for MM1S, and G-016 for RPMI-8226. Green (EGFP) and Red (DsRed) fluo-
rescence were measured 24h later using a BD Accuri C6 flow cytometer (Franklin Lakes, NJ,
USA). A total of 200,000 cells per sample were analyzed. NHEJ efficiency was calculated by di-
viding the number of EGFP positive cells arising from circularized linear plasmid by the num-
ber of transformants arising from parallel transfections of undigested plasmid DNA, after
normalizing from transfection efficiency, X 100.
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Construction of cell lines for detecting NHEJ efficiency
U266, JJN3, LINF692 and LINF903 were transfected with 1 μg of the NHEJ-C reporter con-
struct linearized by digestion with NheI [22]. G418 was added at 500 μg/ml 3 days post-trans-
fection and stable pools were obtained after 3 weeks of selection, in the case of U266 and JJN3,
or 2 months for LINF cell lines. Medium containing G418 was changed every 3 days. To mea-
sure NHEJ efficiency in stable pools, cells were transfected with 5 μg of plasmid encoding
I-SceI endonuclease and 2 μg of pDSRed2-N1. NHEJ efficiency was calculated 24h later as the
ratio of GFP+/DsRed+ cells.
Repair fidelity assay
EcoRI-linearized pUC18 plasmids were transfected into MM cell lines using the programs and
conditions detailed above. Successful repair results in re-circularization of the plasmid with res-
toration of β-galactosidase activity. Plasmid DNA was extracted from the cells 24h post-trans-
fection [QIAprep spin miniprep kit (Qiagen, Germany)], and transformed into E. coli DH5α
cells. After plating on agar plates containing IPTG and X-Gal (Sigma-Aldrich), numbers of
white and blue colonies were counted. The nature of misrepair was analyzed in plasmids ob-
tained from white colonies by PCR and sequencing of the breakpoint junction. The primers
used were: pUC18-5, cggcatcagagcagattgta, and pUC18-3, tggataaccgtattaccgcc.
HR assays
The HR reporter plasmid was used to determine the in vivo levels of HR [22]. The plasmid
was digested with the restriction enzyme SceI and purified. To evaluate the transfection effi-
ciency 2 μg of the HR construct, together with 2 μg of pDsRed-N1, were cotransfected into the
cells using the conditions and programs detailed for the NHEJ assays. GFP+ and DsRed+ were
quantified by flow cytometry 48h after transfection. One million events per sample were ana-
lyzed. Efficiency of HR was calculated by dividing the number of GFP+ cells arising from the
linear plasmid by the number of DsRed+ cells.
Statistic
Differences between the data were assessed for statistical significance using the Student's un-
paired two tailed t-test with the Simfit statistical software version 7.0.5 (http://www.simfit.org.
uk/).
Results
Several MM cell lines exhibit persistent DSBs and a strong G2/M
checkpoint response after irradiation
To analyze DSB formation and repair we first monitored the phosphorylation of H2AX
(γH2AX), a sensitive marker of DSBs [23], after treatment with 2 Gy of ionizing radiation (IR).
γH2AX signal was quantified by flow cytometry in 7 MM cells lines and compared to 5 cell
lines (3 lymphoblastoid cell lines obtained from normal lymphocytes, HeLa and HCT116), that
were used as repair-proficient controls (Fig. 1A). We found that γH2AX intensity reached its
maximum at 1h post-IR in most of the cell lines analyzed, and started to fall over the next 24h.
However, whereas γH2AX signal decreased with a fast kinetics in controls and U266 cells, and
with an intermediate kinetics in IM9 and H929 cells, the reduction of γH2AX was slower in
OPM2, JJN3, MM1S and especially in RPMI-8226, which suggests a defect in DSB repair at
least in these 4 MM cell lines. Residual γH2AX, quantified as the ratio of the signal at 24h post-
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IR/signal in non-irradiated cells, showed significantly higher values in OPM2, JJN3, MM1S
and RPMI-8226 than in LINF control cell lines (Fig. 1B).
To corroborate the results obtained by flow cytometry, we analyzed γH2AX foci at different
times post-IR (2 Gy). In the absence of treatment, all MM cell lines, with the exception of IM9
and U266, exhibited more γH2AX foci than controls (Fig. 2A), in agreement with a previous
report that described increased endogenous DNA damage in MM cells [24]. We found that
OPM2, JJN3, MM1S, and RPMI-8226 were able to repair many IR-induced breaks, since foci
numbers decreased from 1h to 7h and 24h post-IR (Fig. 2A). Even so, the percentage of cells
with γH2AX foci (Fig. 2B) and the number of foci per cell at 7h and 24h post-IR (Fig. 2C and
2D) was higher in those cells lines than in U266, H929 or LINF control cells, which corroborat-
ed the results previously obtained by flow cytometry. We observed that most of the γH2AX
foci present at 24h post-IR colocalized with Rad51 foci (Fig. 2A). Next, we analyzed the repair
kinetics of IR-induced DSBs using the neutral comet assay. Surprisingly, no statistically signifi-
cant differences were found in the kinetics of DSB repair between MM and control LINF cell
lines (Fig. 3). In all the cases most of the DNA damage seemed to be repaired 6h after irradia-
tion, despite the high irradiation dose applied (40 Gy), in agreement with results previously de-
scribed in other non myeloma cell lines [25]. These results indicate that MM cells are able to
repair most of the IR-induced DSBs, while the subset of persistent DSBs in OPM2, JJN3,
MM1S and RPMI-8226, identified as γH2AX foci, might correspond to lesions, especially diffi-
cult to repair in these MM cell lines, and below the comet assay detection limit (on the order of
50–75 breaks per cell, as previously described [25]).
Cell cycle checkpoints are activated following induction of DSBs to provide time for the re-
moval of the damage. The G2/M checkpoint has been described to efficiently retain cells in G2
until they contain less than 10–20 DSBs [26]. The fact that OPM2, JJN3, MM1S, and RPMI-
8226 exhibited more γH2AX foci at 7 and 24h post-IR than the rest of the cell lines, prompted
us to analyze the effect of ionizing radiation on cell cycle progression (Fig. 4A). We found that
fast-growing HeLa and IM9 cells exhibited cell cycle arrest at 7h post-IR, but at 24h cells had
repaired the lesions and escaped G2 arrest. Accordingly, HeLa and IM9 cell number increased
1.6±0.06 and 3.05±0.53-fold, respectively, at 24h post-IR compared to those present before
irradiation. On the contrary, OPM2 and JJN3, with a doubling time similar to HeLa cells
(indicated in Fig. 4A), also exhibited cell cycle arrest at 7h post-IR, but remained blocked at
G2 phase at 24h post-IR and no increment in cell numbers were found 24h post-treatment
(0.98±0.07 and 0.99±0.1-fold, respectively). U266, MM1S and RPMI-8226, were not arrested at
7h, probably due to their slower growth rate (doubling times from 30 to 39 hours). However,
whereas MM1S and RPMI-8226 showed a clear G2 arrest at 24h post-IR and no increase in cell
numbers before and 24h after irradiation were detected (0.8±0.25, and 1.1± 0.1-fold, respec-
tively), U266 was not arrested in G2 at 24h, and a small increase in cell number was observed
(1.3±0.2-fold). To further confirm that U266 was not arrested in G2 because most of the IR-in-
duced lesions have been repaired (Fig. 2A to 2D), the level of damage was increased using 10
Gy of IR, and the cell cycle profile was analyzed at 24h post-IR (S1 Fig.). We observed that the
population of U266 cells arrested in G2 at 24h post-IR also increased, indicating that this cell
Fig 1. Kinetics of γH2AX loss following IR. (A) Asynchronous cells were treated with 2 Gy IR, fixed at the
indicated times post-irradiation, and stained with anti- γH2AX and secondary fluorescent antibodies. Kinetics
of γH2AX disappearance is illustrated for each cell line by a histogram, showing the levels of γH2AX at
different times post-IR, and a graphic, where the mean intensity of γH2AX (in arbitrary units) is plotted. Best
representative from several independent experiments is shown. Similar results were obtained for all LINF cell
lines (only LINF167 is shown). (B) Residual γH2AX, quantified as the ratio of the signal at 24h post-IR/signal
in non-irradiated cells, was obtained as the mean of three independent experiments. Error bars correspond to
standard deviation (SD) (** p<0.01, * p<0.05, compared to LINF cells, Student's t-test).
doi:10.1371/journal.pone.0121581.g001
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line is able to activate the DNA damage checkpoint. To confirm that G2 accumulation was due
to prolonged checkpoint activation, cells were irradiated in the absence or in the presence of
different checkpoint inhibitors. We used caffeine (4 mM), a well known inhibitor of DNA
damage checkpoint sensor kinases ATM and ATR, UCN-01 (100 nM), which inhibits Chk1
(the downstream substrate of ATR) [27] and wortmannin (10 μM), which efficiently inhibits
ATM and DNA-PK [28]. Treatment with caffeine had no effect on cell cycle distribution in
U266, as expected, but efficiently abolished the G2 accumulation observed 24h post-IR in
Fig 2. γH2AX foci after exposure to IR (2 Gy). (A) Representative images of γH2AX foci in untreated cells, and in cells irradiated with 2 Gy 1h, 7h and 24h
post-IR. Rad51 foci in cells at 24h post-IR are also shown. (B) Percentage of cells with γH2AX foci at the indicated times post-IR. (C) and (D)
Quantification of the number of γH2AX foci per cell at 7 and 24h post-IR. In all quantifications data represent the mean values of at least 2 independent
experiments. (** p<0.01, * p<0.05, compared to LINF cells). A minimum of 100 cells per experiment and cell line were counted.
doi:10.1371/journal.pone.0121581.g002
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OPM2, JJN3 and MM1S (Fig. 4B), confirming that G2 accumulation was induced by check-
point activation. Treatment with UCN-01 but not with wortmannin inhibited the G2 check-
point in irradiated JJN3 cells, indicating that ATR was responsible for the G2 arrest in these
cells. However, checkpoint activation seemed to depend on ATR but also on ATM/DNA-PK in
Fig 3. Analysis of DSB repair by the neutral comet assay. (A) Cells were irradiated with 40 Gy of IR and mean tail moment calculated at different time
points using the OpenComet software. Data represent mean values, after subtraction of background damage, of three independent experiments ± SD. At
least 100 cells were scored per sample and experiment. (B) Representative images of one experiment.
doi:10.1371/journal.pone.0121581.g003
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OPM2 and MM1S (Fig. 4B), since treatment with UCN-01 and wortmannin abolished the G2
accumulation in these cell lines. It has been reported that high concentrations of caffeine could
by itself induce G1 arrest [29]. To distinguish the effect of caffeine on abolishing G2/M check-
point from its putative effect on G1 arrest, cells were irradiated with 2 Gy IR and 24h later,
when MM cells were already blocked at G2, caffeine was added and maintained for a 6h period
(Fig. 4C). We observed that treatment with the ATM/ATR inhibitor for 6h clearly diminished
the amount of cells in G2 in OPM2, JJN3, MM1S and RPMI-8226, confirming that caffeine in-
hibited the G2 arrest. Importantly, we also observed that the 6h treatment resulted in dephos-
phorylation of γH2AX (Fig. 4D). This result indicated that the prolonged H2AX
phosphorylation observed after irradiation depended on the presence of unrepaired DNA dam-
age that signaled through the checkpoint kinases to H2AX, and not to defects in the dephos-
phorylation of the histone variant.
Several MM cell lines are hypersensitive to IR and addicted to a
functional G2 checkpoint for survival
As it has been described that cells retaining γH2AX foci at 24 h post-IR are more sensitive to
IR [25,30,31,32], we further analyzed the survival of MM cell lines after different doses of IR by
Annexin V/PI staining. The results showed that OPM2, JJN3, RPMI-8226 and MM1S were
more sensitive to IR than U266 and H929 (p< 0.01) and control cell lines LINF167 and
LINF692 (Fig. 4E).
We then reasoned that since the G2/M checkpoint response was stronger in some MM cell
lines, these cells could exhibit a greater dependence on a functional checkpoint for survival to
IR. To test this hypothesis, MM cell lines were irradiated, and 24h later, when repair-proficient
cells should have repaired most of the DSBs, caffeine was added and maintained for a new 24h
period. Treatment with the G2 checkpoint inhibitor for 24h increased cell death of irradiated
JJN3, MM1S and RPMI-8226 cells, whereas it had no significant effect on H929, U266, or
LINF control cells (Fig. 4F). These results confirmed our hypothesis and indicated that check-
point responses are essential to protect some MM cell lines from cell death induced by
DNA damage.
Upregulation of proteins involved in DSB repair pathways in MM
To further investigate DSB repair in MM cells we examined the steady-state levels of proteins
involved in the two main pathways of DSB repair: NHEJ and HR. For this purpose, western
blot analysis was performed in the 7 MM cell lines and compared with controls (3 LINF control
cell lines and HeLa cells). No significant differences in protein levels of the key NHEJ proteins
(Ku86, Ku70 and DNA ligase IV) were found among the samples (Fig. 5A). However,
DNA-PKcs showed higher expression in 6 out of the 7 MM cell lines compared to controls.
XRCC4 was clearly upregulated and Artemis was also increased in all MM cell lines compared
to control cells (see quantifications in S2 Fig.).
Fig 4. Cell cycle phase distribution and cell survival after exposure to IR. (A) Cell cycle analysis. Cells were fixed at the indicated times post-IR and DNA
content was measured by flow cytometry. Percentages of cells in the different phases of the cell cycle are indicated and duplication times (DT) were
calculated (http://www.doubling-time.com/compute.php). Best representative from several independent experiments is shown. (B) Cell cycle distribution of
cells at the indicated times post-IR (2 Gy) in the presence or in the absence of the checkpoint inhibitors (caffeine, UCN-01 and wortmannin). (C) Caffeine
(4 mM) was added 24h post-IR and maintained for 6h. (D) Levels of γH2AX (in arbitrary units) in the absence of treatment (-IR), 1h, 30h post-IR and 30h post-
IR with the last 6h in the presence of caffeine. Data are the mean of two independent experiments. (E) Cells were irradiated with the indicated doses of IR and
72h later cell viability was evaluated by annexinV/PI staining. Data are the mean ± SD of three independent experiments (** p<0.01, * p<0.05 in OPM2,
JJN3, RPMI-8226 and MM1S compared to LINF cells). (F) Increase in the percentage of cell death compared to untreated samples after the indicated
treatments. Asterisks in samples treated with caffeine indicate significant values related to irradiated cells (** p<0.01, * p<0.05).
doi:10.1371/journal.pone.0121581.g004
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Recent studies have shown the existence of an alternative NHEJ pathway (Alt-NHEJ) that
mainly operates as a backup pathway [13]. Therefore, we analyzed the steady-state levels of sev-
eral proteins involved in this pathway. Levels of PARP-1 were found similar in all the samples
analyzed (Fig. 5B), whereas WRN protein was found upregulated in 6 out of the 7 MM cell
lines. Of note, we found that all MM cell lines expressed higher levels of DNA ligase IIIα than
controls, with MM1S, U266, JJN3 and specially OPM2 exhibiting the higher expression
(Fig. 5B, see lower exposition and quantifications in S2 Fig.). Expression of DNA ligase IIIα in
these cell lines was similar to that exhibited by K562, a chronic myeloid leukemia (CML) cell
line previously shown to overexpress this protein [33] (Fig. 5C). Since DNA ligase IIIα has
been extensively implicated in Alt-NHEJ [34,35,36,37], we decided to monitor the levels of this
protein in plasma cells (PCs) isolated from patients with MM. We observed that the protein
was upregulated in 3 out of the 5 samples analyzed, as compared with the linfoblastoid cell line,
LINF167, used as control (Fig. 5D). Finally, we found that Rad51, a protein that plays an essen-
tial role exclusively in HR, was clearly upregulated in all MM cell lines (Fig. 5B).
NHEJ efficiency is increased in MM cells
To investigate the efficiency of NHEJ in MM we employed an extrachromosomal assay where
end joining is determined by measuring the ability of the cells to recircularize an enzyme-
Fig 5. Western blot analysis of proteins involved in DSB repair in the indicated cell lines. (A) Proteins involved in the classical NHEJ pathway. (B)
Levels of Alt-NHEJ proteins and the HR protein Rad51. (C) Levels of DNA ligase IIIα in LINF, MM and CML (K562) cell lines. (D) DNA ligase IIIα in plasma
cell samples isolated from patients.
doi:10.1371/journal.pone.0121581.g005
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digested plasmid (Fig. 6A). Plasmid recircularization results in the formation of the green fluo-
rescent protein (GFP), and GFP+ cells can be easily detected and quantified by flow cytometry.
Fig. 6B shows the fluorescence obtained by transfection of LINF903 cells with different con-
trols. Dot plots of LINF903 and U266, representing cells transfected with the same amount of
circular pEGFP-Pem1 orHindIII-digested pEGFP-Pem1-Ad2 plasmids, together with
pDSRed2-N1, used to correct for transfection efficiency, are shown in Fig. 6C. We found that
the number of GFP+ cells obtained by transformation with the linear, HindIII-digested, plas-
mid was higher in U266 than in LINF903 control cells, (Fig. 6C). In fact, frequency of NHEJ of
HindIII or SceI-digested plasmids (calculated by dividing numbers of GFP+ cells obtained by
religation of the linearized plasmid by numbers of GFP+ cells obtained by transformation with
the undigested plasmid, after normalizing for transfection efficiency), was found higher in
most of the MM cell lines compared with LINF control cells, revealing an overactivation of
NHEJ repair in MM (Fig. 6D).
To corroborate these results obtained using episomal plasmids, we used an intrachromoso-
mal substrate, NHEJ-C, that was integrated into the chromatin of U266, JJN3 and control
LINF cell lines. DSBs were generated by transfection of the stable cell lines with a I-SceI endo-
nuclease-expressing plasmid, and NHEJ efficiency was estimated 24h later as the ratio of GFP
+/DsRed+ cells. We found that NHEJ efficiency was significantly higher in MM compared to
control LINF cell lines (Fig. 6E).
MM cells show increased DNA deletions and microhomology use at
DNA junctions
To molecularly characterize end joining repair, we used another in vivo assay that allows the
calculation of different repair parameters: misrepair frequency, deletion size and use of micro-
homology at the repair junction. These parameters, when increased, indicate a higher use of
the Alt-NHEJ pathway [13]. The assay consists on the transfection of EcoRI-digested pUC18
plasmid into the cells, the subsequent recovery of recircularized pUC18 from them, and trans-
formation of bacterial cells for plasmid amplification and analysis. Since Alt-NHEJ proteins
were found upregulated in all MM cells, we selected for the analysis those with higher transfec-
tion efficiency, U266, JJN3, and MM1S. Lymphoblastoid cells were used as healthy controls, al-
though their low transfection efficiency and high transfection-associated cell death made us
perform 50 transfections to obtain enough number of bacterial colonies for the analysis. Fre-
quency of misrepair, that is white colonies (incorrectly repaired) vs total colonies (blue [cor-
rectly repaired]+ white), was found similar in U266, JJN3, MM1S, LINF692 and LINF167 cells
(10.9± 2.2, 9.75± 1.62, 8.6±1.5, 10.05± 1.9 and 9.3± 2.5, respectively, was the mean of three in-
dependent experiments). However, PCR analysis, and sequencing of plasmids obtained from
15 white colonies from U266, JJN3, MM1S and LINF cells showed a clear increase in the num-
ber of large deletions in MM cells lines compared to LINF controls (Fig. 6F and 6G). Moreover,
whereas a small percentage of DSBs were repaired using DNA sequence microhomology in
lymphoblastoid cells, more than 40% of the breaks were repaired by a microhomology-mediat-
ed mechanims in U266, JJN3 and MM1S cells (Fig. 6G, panel 2). Deletion size and microho-
mology lengh are detailed in Tables A-E in S1 File. These results suggest that a high percentage
of DSBs in MM cells may be repaired by Alt-NHEJ pathways, resulting in abnormal and highly
mutagenic repair characterized by large DNA deletions and the use of sequence microhomol-
ogy. To further demonstrate that these features were due to a higher use of the Alt-NHEJ path-
way in MM, repair junctions were sequenced after chemical inhibition of several proteins
involved in the pathway. U266 cells were treated with mirin, an inhibitor of the Mre11-Rad50-
Nbs1 complex required for DNA resection and involved in both HR and Alt-NHEJ [38,39],
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and with NU1025, an inhibitor of PARP-1, a protein that has also been involved in the Alt-
NHEJ pathway [40]. Treatment of U266 cells with 100 μMmirin, the concentration described
to inhibit the MRN exonuclease activity [38], and 50 μMNU1025 reduced misrepair frequency
from 12.3± 1.2 in the absence of treatment, to 5.3± 1.1 in the presence of the inhibitors (mean
of three independent experiments, p<0.01). Sequencing of 15 plasmids derived from white col-
onies indicated that the presence of the chemical inhibitors clearly decreased both deletion size
and microhomology use (Fig. 6H, panels 1 and 2, and Tables F-G in S1 File). We could not per-
form the experiment in JJN3 and MM1S because treatment with mirin resulted in a high per-
centage of cell death in these cell lines (more than 80% of the cells died compared to 40% in
U266). We hypothesize that cell death could be related to a stronger requirement in JJN3 and
MM1S of the MRN complex to repair their higher levels of endogenous DSBs (Fig. 2A).
To determine whether the increased activity of the Alt-NHEJ pathway in MM cells could be
responsible for the higher frequency of NHEJ detected in the plasmid reactivation assays
(Fig. 6D), we tested the effect of classical NHEJ inhibition, by the use of the specific DNA-PK
inhibitor NU7026, on the efficiency of NHEJ in U266, MM1S, JJN3 and LINF control cells. Al-
though the percentage of NHEJ remaining after DNA-PK inhibition was high (around 50%, in
agreement with a previous report using DNA-PK mutants [41]), no significant differences
were observed between MM and control LINF cells (Fig. 6I). These results suggest that the in-
creased total NHEJ efficiency detected in MM cell lines compared to controls (Fig. 6D) seems
to depend on the overactivation of both classical and DNA-PK-independent (included Alt-
NHEJ) DSB repair pathways.
HR efficiency is increased in MM cells
To analyze HR activity in MM we used the HR reported construct shown in Fig. 7A. The plas-
mid was linearized by digestion with SceI and transfected into different MM and LINF cells
lines. HR efficiency, calculated as the ratio of GFP+ cells to DsRed+, is shown in Fig. 7B. Inter-
estingly, a significant increase of recombination activity was observed in all MM cell lines com-
pared to control LINF cells (Fig. 7B and 7C).
Discussion
DSBs are the most deleterious form of DNA damage; if left unrepaired they can cause cell
death, if misrepaired, they lead to genomic instability and, ultimately, to the development or
progression of cancer [42]. To handle this constant an inevitable threat, cells have developed
several DSB repair pathways: HR, considered error free, although when constitutively activated
Fig 6. Analysis of NHEJ in MM cells. (A) Map of pEGFP-Pem1-Ad2 modified from reference [36]. (B) Dot plots of nontransfected LINF903 cells (panel 1),
LINF903 cells transfected with 2 μg pDSRed2-N1 (panel 2), with 0.5 μg of pEGFP-Pem1 (panel 3), or with both plasmids together (panel 4). Numbers of
green and red cells were determined 24h after transfection by FACS. (C) Dot plots of LINF903 and U266 cell lines transfected with 0.5 μg of pEGFP-Pem1 or
0.5 μg of HindIII-digested pEGFP-Pem1-Ad2 plasmid, together with 2 μg of pDSRed2-N1. Total represented events were adjusted to correct for differences
in transfection efficiencies, and same numbers of cells transfected with circular and/or control pDSRed2-N1 are shown (6,000 cells). These numbers of
events were then represented in panels corresponding to transfections with digested molecules. (D) Percentage of NHEJ of HindIII- or SceI-digested plasmid
in different cell lines. Mean of a minimum of three independent experiments is shown. (** p<0.01, * p<0.05, compared to LINF cells). (E) NHEJ efficiency in
LINF, JJN3 and U266 cell lines carrying the integrated NHEJ reporter cassette. Stable pools were transfected with 5 μg of I-SceI endonuclease-expressing
plasmid and 2 μg pDSRed2-N1 to correct for differences in transfection efficiencies. GFP+ and DsRed+ cells 24h after transfection are shown in panel 1 (A
total of 6,000 GFP+ and/or red+ cells are shown). NHEJ efficiency was calculated as the ratio of GFP+/DsRed+ cells (panel 2). Data are the mean of three
independent experiments (** p<0.01, compared to LINF cells). (F) Agarose gel showing PCR products of misrepaired products (1–14). The size of the PCR
product from a correctly repaired DSB (c) is 628 bp. (G) Percentage of large deletions (20 bp, panel 1) and percentage of misrepaired plasmids using
sequence microhomology (2 bp, panel 2) in LINF, U266, JJN3, and MM1S cell lines. (H) Deletion size (panel 1) and percentage of microhomology (panel 2)
in plasmids recovered from U266 cells treated or not with mirin (100 μM) and NU1025 (50 μM). Cells were pretreated with the chemical inhibitors for 6h,
transfected with EcoRI-digested plasmid, and cultured for 18h in the presence of the chemical inhibitors. (I) NHEJ activity remaining after inhibition of
DNA-PKcs. Cells were transfected as in (C), and grown in the presence of 10 μM of NU7026.
doi:10.1371/journal.pone.0121581.g006
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can generate genomic rearrangements and lead to oncogenic activation [12], NHEJ, that can
result in small insertions or deletions at the junction site, and Alt-NHEJ, a backup, highly mu-
tagenic pathway that has been implicated in chromosomal translocation in mouse cells, [14].
In this study, we show that the three DSB repair pathways are upregulated in MM cells, both at
the level of function and protein expression. This aberrant activation of DSB repair pathways,
could contribute to the enormous genome instability found in MM.
Our initial experiments, measuring the repair kinetics of IR-induced DSBs by H2AX phos-
phorylation, suggested a defect in DSB repair in 4 out of 7 MM cell lines analyzed (Figs. 1 and
2). In agreement with our results, persistence of γ-H2AX foci 24h following irradiation has pre-
viously been reported for the RPMI-8226 MM cell line [43]. However, the neutral comet assay
did not detect differences in repair kinetics between MM and normal control lymphoblastoid
cells, which strongly suggests that MM cells are able to repair the majority of the breaks. We
speculate that the higher percentage of large, and highly brilliant, γH2AX foci detected at long
times after IR in OPM2, JJN3, MM1S and RPMI-8226, may correspond to persistent DSBs that
could be under the limit of detection of the neutral comet assay (on the order of 50–75 breaks,
as previously described [25]). In fact, most of the residual γH2AX foci were colocalized with
the recombinase Rad51, which has also been found in association with persistent DSBs [44].
The subset of DSBs observed in these cell lines could represent lesions especially difficult to re-
pair because of their complexity or to local chromatin organization.
Additional evidence for the presence of higher numbers of persistent DSBs in some MM cell
lines came from the analysis of the cell cycle after treatment with IR. It has been described that
duration of IR-induced G2/M cell cycle arrest depends on the level of damage and repair capac-
ity. Thus, cells exposed to low levels of IR (below 2 Gy) usually do not show G2 arrest at 24h
post-IR, whereas cells exposed to higher dose (10 Gy) show a clear cell cycle arrest [25]. On the
Fig 7. Analysis of HR in normal LINF andMM cell lines. (A) Reporter plasmid for detection of HR [22]. (B) Cells were transfected with 2 μg of SceI-digested
HR plasmid together with 2 μg of pDSRed2-N1 to normalize for the differences in transfection efficiency. Numbers of green and red cells were determined 48h
after transfection by FACS. The ratio of GFP+ cells to DsRed+ cells was used as a measure of repair efficiency. Data are means ± SD of three independent
experiments. (C) Representative images showing dot plots corresponding to the indicated cell lines. A total of 6,000 GFP+ and/or DsRed+ cells are shown.
(** p<0.01, compared to LINF cells).
doi:10.1371/journal.pone.0121581.g007
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other hand, it has been shown that checkpoint release occurs later in cells that accumulate
DSBs, like those with defects in DNA repair, even when low doses of IR are applied [45]. Here,
we show that the four MM cell lines exhibiting residual γH2AX foci also displayed a prolonged
G2/M checkpoint activation 24h after 2 Gy. A plausible interpretation of these results is that
the prolonged G2/M checkpoint activation arises from the presence of a subset of unrepaired
DSBs in numbers enough to induce a persistent arrest. However, some defect in the checkpoint
response cannot be ruled out. It is possible that MM1S and RPMI8226 cell lines present a G1
checkpoint deficiency compared to the control lines (Fig. 4A, 7H post-IR), which may lead to a
replication stress and the appearance of spontaneous γH2AX foci.
Previous reports have shown that cell lines that retain higher numbers of γ-H2AX or Rad51
foci 24h post-IR are more sensitive to IR [25,30,31] and that persistent or irreparable DSBs in-
duce cell death [32]. Therefore, the higher percentage of cells exhibiting H2AX foci 24h post-
IR in OPM2, JJN3, MM1S and RPMI-8226, compared to the rest of the cell lines, possibly un-
derlies their radiosensitive phenotype. We also propose that the prolonged G2/M arrest exhib-
ited by these MM cell lines after irradiation is important for their survival, as shown by the
increase in cell death after treatment with the checkpoint inhibitor caffeine.
The in vivoNHEJ functional assays indicate the absence of general DSB repair defects in
MM. Moreover, 4 out of 5 MM cell lines analyzed exhibited an elevated NHEJ activity com-
pared with normal lymphoblastoid cells (Fig. 6D). The analysis of proteins involved in NHEJ
revealed no changes in the levels of Ku70 or Ku86 compared to controls. However, an upregu-
lation of DNA-PKcs, Artemis and XRCC4 was found. Interestingly, higher expression of
XRCC4 has previously been reported in tumor samples isolated from patients with MM [46].
The upregulation of these NHEJ proteins is likely to contribute to the increased repair efficien-
cy observed in MM cells. On this regard, a 4-fold increase in DNA-PKcs, and higher levels of
NHEJ have also been described in CML compared to normal cells [11]. Moreover, high
DNA-PKcs levels in chronic lymphocytic leukemia have been associated with poor prognosis
[47]. NHEJ is not intrinsically inaccurate, but is versatile and adaptable to imperfect ends,
which may result in short deletions or insertions [7]. Therefore, overactivity of this pathway
may generate mutations, or even alignment of noncontiguous broken DNA ends, leading to
translocations and deletions [11]. Overactivation of the NHEJ pathway would be especially
dangerous in the presence of high levels of DNA damage.
Deregulation of the HR pathway also contributes to genome instability [10,12]. Thus, over-
expression of Rad51 directly induces genome instability in the form of deletions, aneuploidy
and multiple chromosomal rearrangements [48,49]. In CML, overactivation of the HR pathway
has been described [50]. In MM, increased levels of RAD51 and related genes, concomitant
with an upregulated HR activity have previously been reported [51]. Our results confirm the
increased levels of the recombinase Rad51 in all MM cell lines tested. Moreover, using a
completely different HR functional assay, we show that HR activity is elevated in MM cells
compared to normal lymphoblastoid controls.
Here, we describe for the first time, that MM cells also show elevated levels of proteins in-
volved in Alt-NHEJ and an increased activity of this pathway, revealed by larger DNA deletions
and higher microhomology use at repair junctions than control cells, that were reduced by
chemical inhibition of the pathway. Moreover, upregulation of the Alt-NHEJ protein DNA li-
gase IIIα was also observed in plasma cells isolated from patients with MM. Interestingly, in-
creased levels of DNA ligase IIIα have also been described in acute myeloid leukemia (AML)
and CML, and a connection between increased Alt-NHEJ pathway and genome instability that
drives disease progression has been proposed [33,52]. Levels of DNA ligase IIIα in MM cell
lines were found to be similar to those exhibited by the CML cell line K562 (Fig. 5C). Although
the rationale for altered levels of DNA ligase IIIα in CML or AML is not clear, it seems related
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to the constitutively activated kinase activities, and with lowered levels of some proteins in-
volved in the canonical NHEJ [33,52]. However, this aspect remains controversial, since high
levels of some proteins involved in classical NHEJ, together with increased NHEJ efficiency has
also been described in CML [11]. In MM, we found that proteins involved in NHEJ are either
unchanged or upregulated, and the activity of NHEJ was also elevated, suggesting that other
causes may be responsible for DNA ligase IIIα protein upregulation.
The most likely explanation for the increased activity/protein levels of the three DSB repair
pathways in MM (HR, NHEJ and Alt-NHEJ), would be the high level of endogenous DNA
damage described in MM cells [24]. However, we cannot rule out the impact of additional fac-
tors, commonly upregulated in MM that could affect the expression of proteins involved in
DSB repair. Thus, c-MYC, is known to upregulate Rad51 [53], NFkB, has been shown to in-
crease HR [54], and KRAS has recently been associated with increased DNA ligase IIIα expres-
sion and preferential use of microhomology for end joining [55]. The contribution of these
individual factors to DSB repair in MM needs to be further investigated.
In summary, our results show that NHEJ, HR and Alt-NHEJ pathways are stimulated in
MM, in agreement with several reports that previously analyzed DSB repair in other hemato-
logical malignancies. Overactivation of the three repair pathways, and a putative competitive
imbalance between them, might result in the emergence of genetic changes leading to disease
progression and acquisition of drug resistances. In addition, the data reported here may be ex-
ploited therapeutically [56]. Given that many MM cell lines rely on a functional damage check-
point, and exhibit increased activity of repair pathways, a therapy with checkpoint inhibitors
and/or targeting these pathways would probably benefit MM patients. In fact, inhibitors of
PARP, DNA ligase IIIα, and checkpoint proteins have been developed and are being tested for
cancer treatment [56,57]. Interestingly, a combination of PARP and DNA ligase IIIα inhibitors
has been recently assayed in vitro for the treatment of CML with promising results [56].
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S1 Fig. Cell cycle phase distribution of U266 before treatment (-IR) and 24h post-irradia-
tion (2 Gy or 10 Gy). Percentages of cells in the different phases of the cell cycle are indicated.
(TIF)
S2 Fig. Quantification of proteins. Band intensities were quantified using ImageJ, normalized
to tubuline and calculated relative to LINF167 control cells. Error bars, when indicated, repre-
sent the standard deviation. Data shown are representative of at least two independent experi-
ments. ( p<0.01,  p<0.05, compared to LINF cells). (A) Proteins involved in the classical
NHEJ pathway. (B) Levels of Alt-NHEJ proteins and the HR protein Rad51. (C) Levels of DNA
ligase IIIα in LINF, MM and CML (K562) cell lines. (D) DNA ligase IIIα in plasma cell samples
isolated from patients.
(TIF)
S1 File. Tables A-G. Sequence analysis of misrepaired plasmids from LINF692, LINF167,
U266, JJN3 and MM1S. EcoRI site (GAATTC) is located at position 450–455 of plasmid
pUC18 (indicated in lower case). Original sequences flanking the junctions are indicated. Nu-
cleotides in the original sequences that are physically present after repair are underlined.
Bolded nucleotides indicate microhomologies. After ligation only one copy of the microhomol-
ogy sequence is preserved. Sequences marked in grey indicate insertions. Table A. LINF692.
Table B. LINF167. Table C. U266. Table D. JJN3. Table E. MM1S. Table F. U266 in the absence
of Alt-NHEJ protein inhibition. Table G. U266 with Alt-NHEJ protein inhibition.
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